Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders J Rehm, C Mathers, S Popova, M Thavorncharoensap, ... The lancet 373 (9682), 2223-2233, 2009 | 4304 | 2009 |
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment OJ Wouters, KC Shadlen, M Salcher-Konrad, AJ Pollard, HJ Larson, ... The Lancet 397 (10278), 1023-1034, 2021 | 1121 | 2021 |
Essential medicines for universal health coverage VJ Wirtz, HV Hogerzeil, AL Gray, M Bigdeli, CP de Joncheere, MA Ewen, ... The Lancet 389 (10067), 403-476, 2017 | 541 | 2017 |
Risk factors of breast cancer: a systematic review and meta-analysis T Anothaisintawee, C Wiratkapun, P Lerdsitthichai, V Kasamesup, ... Asia Pacific Journal of Public Health 25 (5), 368-387, 2013 | 264 | 2013 |
The international decision support initiative reference case for economic evaluation: an aid to thought T Wilkinson, MJ Sculpher, K Claxton, P Revill, A Briggs, JA Cairns, ... Value in health 19 (8), 921-928, 2016 | 220 | 2016 |
The economic impact of alcohol consumption: a systematic review M Thavorncharoensap, Y Teerawattananon, J Yothasamut, ... Substance abuse treatment, prevention, and policy 4, 1-11, 2009 | 216 | 2009 |
Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries K Chalkidou, P Marquez, PK Dhillon, Y Teerawattananon, ... The lancet oncology 15 (3), e119-e131, 2014 | 170 | 2014 |
Adjusting for inflation and currency changes within health economic studies HC Turner, JA Lauer, BX Tran, Y Teerawattananon, M Jit Value in Health 22 (9), 1026-1032, 2019 | 161 | 2019 |
Multicriteria decision analysis for including health interventions in the universal health coverage benefit package in Thailand S Youngkong, R Baltussen, S Tantivess, A Mohara, Y Teerawattananon Value in health 15 (6), 961-970, 2012 | 160 | 2012 |
Priority-setting for achieving universal health coverage K Chalkidou, A Glassman, R Marten, J Vega, Y Teerawattananon, ... Bulletin of the World Health Organization 94 (6), 462, 2016 | 148 | 2016 |
Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand Y Teerawattananon, M Mugford, V Tangcharoensathien Value in health 10 (1), 61-72, 2007 | 147 | 2007 |
Risk prediction models of breast cancer: a systematic review of model performances T Anothaisintawee, Y Teerawattananon, C Wiratkapun, V Kasamesup, ... Breast cancer research and treatment 133, 1-10, 2012 | 140 | 2012 |
The EQ-5D-5L valuation study in Thailand J Pattanaphesaj, M Thavorncharoensap, JM Ramos-Goñi, S Tongsiri, ... Expert review of pharmacoeconomics & outcomes research 18 (5), 551-558, 2018 | 110 | 2018 |
Priority-setting institutions in health: recommendations from a center for global development working group A Glassman, K Chalkidou, U Giedion, Y Teerawattananon, S Tunis, ... Global heart 7 (1), 13-34, 2012 | 107 | 2012 |
Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter? M Thavorncharoensap, Y Teerawattananon, S Natanant, W Kulpeng, ... ClinicoEconomics and outcomes research, 29-36, 2013 | 100 | 2013 |
Universal coverage of renal dialysis in Thailand: promise, progress, and prospects S Tantivess, P Werayingyong, P Chuengsaman, Y Teerawattananon Bmj 346, 2013 | 94 | 2013 |
A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers? Y Teerawattananon, S Russell, M Mugford Pharmacoeconomics 25, 467-479, 2007 | 93 | 2007 |
Economic evaluation of policy options for prevention and control of cervical cancer in Thailand N Praditsitthikorn, Y Teerawattananon, S Tantivess, S Limwattananon, ... Pharmacoeconomics 29, 781-806, 2011 | 90 | 2011 |
The economic costs of alcohol consumption in Thailand, 2006 M Thavorncharoensap, Y Teerawattananon, J Yothasamut, ... BMC Public Health 10 (1), 1-12, 2010 | 87 | 2010 |
The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand Y Teerawattananon, N Tritasavit, N Suchonwanich, P Kingkaew Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen 108 (7 …, 2014 | 86 | 2014 |